Cargando…
Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer
Breast cancer is the most common female cancer, affecting approximately one in eight women during their lifetime in North America and Europe. Receptor Activator of NF-kB Ligand (RANKL), its receptor RANK and the natural antagonist osteoprotegerin (OPG) are essential regulators of bone resorption. We...
Autores principales: | Kiechl, Stefan, Schramek, Daniel, Widschwendter, Martin, Fourkala, Evangelia-Ourania, Zaikin, Alexey, Jones, Allison, Jaeger, Bernadette, Rack, Brigitte, Janni, Wolfgang, Scholz, Christoph, Willeit, Johann, Weger, Siegfried, Mayr, Agnes, Teschendorff, Andrew, Rosenthal, Adam, Fraser, Lindsay, Philpott, Susan, Dubeau, Louis, Keshtgar, Mohammed, Roylance, Rebecca, Jacobs, Ian J., Menon, Usha, Schett, Georg, Penninger, Josef M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354797/ https://www.ncbi.nlm.nih.gov/pubmed/28002811 http://dx.doi.org/10.18632/oncotarget.14013 |
Ejemplares similares
-
Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
por: Ming, Jie, et al.
Publicado: (2020) -
Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010) -
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
por: Widschwendter, Martin, et al.
Publicado: (2015) -
RANK/RANKL/OPG system in the intervertebral disc
por: Takegami, Norihiko, et al.
Publicado: (2017) -
Serum levels of RANKL and OPG, and the RANKL/OPG
ratio in bisphosphonate-related osteonecrosis of the jaw: Are they
useful biomarkers for the advanced stages of osteonecrosis?
por: Bagan, Leticia, et al.
Publicado: (2017)